SAN DIEGO, June 2, 2016 /PRNewswire/ -- Sequenom, Inc.
(NASDAQ: SQNM), a life sciences company committed to enabling
healthier lives through the development of innovative products and
services, today announced the Company's participation at the
Jefferies 2016 Global Healthcare Conference in New York, NY on June
10, 2016.
Dirk van den Boom, President and
Chief Executive Officer, will present on Friday, June 10 beginning at 2:30 p.m. ET, to provide an overview of and
update on the Company. The presentation is expected to last
approximately 30 minutes and will be webcast live through the
"Invest" section of the Sequenom Web site
at: http://wsw.com/webcast/jeff97/sqnm
An audio replay will be available for 30 days following the
initial webcast.
About Sequenom
Sequenom, Inc. (NASDAQ: SQNM) is
committed to enabling healthier lives through the development of
innovative products and services. The Company serves patients and
physicians by providing early patient management information. To
learn how Sequenom is interpreting the genome to improve your life,
visit www.sequenom.com.
About Sequenom Laboratories
Sequenom Laboratories, a
CAP-accredited and CLIA-certified molecular diagnostics laboratory,
has developed a broad range of laboratory tests, with a focus
principally on prenatal care. Branded under the names
HerediT®, HerediT® UNIVERSAL,
MaterniT® GENOME, MaterniT® 21 PLUS,
NextView®, SensiGene® and VisibiliT™, these
molecular genetic laboratory-developed tests provide early patient
management information for obstetricians, geneticists, and maternal
fetal medicine specialists. Sequenom Laboratories is changing the
landscape in genetic diagnostics using proprietary cutting edge
technologies. Visit www.laboratories.sequenom.com and follow
@SequenomLabs.
SEQUENOM®, HerediT®, MaterniT®
GENOME, MaterniT® 21 PLUS, NextView®,
SensiGene®, VisibiliT™ and Sequenom Laboratories™ are
trademarks of Sequenom, Inc. All other trademarks and service
marks are the property of their respective owners.
Logo - http://photos.prnewswire.com/prnh/20160225/337675LOGO
To view the original version on PR Newswire,
visit:http://www.prnewswire.com/news-releases/sequenom-to-present-at-jefferies-global-healthcare-conference-300278950.html
SOURCE Sequenom, Inc.